Sigilon Therapeutics Inc.

NASDAQ: SGTX · Real-Time Price · USD
22.47
-0.59 (-2.56%)
At close: Aug 10, 2023, 10:00 PM

Sigilon Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
PE Ratio
-3.39 -1.12
PEG Ratio
0.04 -0.03
PS Ratio
11.39 9.16
PB Ratio
3.77 1.14
P/FCF Ratio
-2.83 -1.1
P/OCF Ratio
-2.86 -1.12
OCF/S Ratio
-3.98 -8.17
Debt / Equity Ratio
0.72 0.43
Quick Ratio
2.39 3.62
Current Ratio
2.40 3.62
Asset Turnover
0.15 0.07
Interest Coverage
-19.07 -38.05
Return on Equity
-1.11 -1.01
Return on Assets
-0.5 -0.54
Return on Invested Capital
-0.65 -0.66
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
1.00 1.00
Net Profit Margin
-3.36 -8.15
Pretax Profit Margin
-3.37 -8.05
Operating Profit Margin
-3.37 -7.88
FCF Margin
n/a n/a
EBITDA Margin
-3.19 -7.85